These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 21818727

  • 1. The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age.
    Zabaneh R, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Dansereau LM, Lin H, Neal C, Lester BM.
    Am J Perinatol; 2012 Mar; 29(3):203-10. PubMed ID: 21818727
    [Abstract] [Full Text] [Related]

  • 2. Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age.
    LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C, Arria A, Huestis MA, DellaGrotta S, Lin H, Dansereau LM, Lester BM.
    Pediatrics; 2012 Apr; 129(4):681-8. PubMed ID: 22430455
    [Abstract] [Full Text] [Related]

  • 3. Behavior Problems During Early Childhood in Children With Prenatal Methamphetamine Exposure.
    Chu EK, Smith LM, Derauf C, Newman E, Neal CR, Arria AM, Huestis MA, DellaGrotta SA, Roberts MB, Dansereau LM, Lester BM.
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 33172920
    [Abstract] [Full Text] [Related]

  • 4. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine.
    Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Haning W, Arria A, Huestis M, Strauss A, Della Grotta S, Dansereau LM, Lin H, Lester BM.
    Neurotoxicol Teratol; 2011 Dec; 33(1):176-84. PubMed ID: 21256431
    [Abstract] [Full Text] [Related]

  • 5. Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years.
    Wouldes TA, Lagasse LL, Huestis MA, Dellagrotta S, Dansereau LM, Lester BM.
    Neurotoxicol Teratol; 2014 Dec; 42():77-84. PubMed ID: 24566524
    [Abstract] [Full Text] [Related]

  • 6. Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: results from the IDEAL study.
    Kiblawi ZN, Smith LM, Diaz SD, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, DellaGrotta S, Dansereau LM, Neal C, Lester B.
    Subst Abus; 2014 Dec; 35(1):68-73. PubMed ID: 24588296
    [Abstract] [Full Text] [Related]

  • 7. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth.
    Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM.
    Pediatrics; 2006 Sep; 118(3):1149-56. PubMed ID: 16951010
    [Abstract] [Full Text] [Related]

  • 8. Prenatal methamphetamine exposure and inhibitory control among young school-age children.
    Derauf C, Lagasse LL, Smith LM, Newman E, Shah R, Neal CR, Arria AM, Huestis MA, Dellagrotta S, Dansereau LM, Lin H, Lester BM.
    J Pediatr; 2012 Sep; 161(3):452-9. PubMed ID: 22424953
    [Abstract] [Full Text] [Related]

  • 9. The effect of prenatal methamphetamine exposure on attention as assessed by continuous performance tests: results from the Infant Development, Environment, and Lifestyle study.
    Kiblawi ZN, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, DellaGrotta S, Dansereau LM, Neal C, Lester B.
    J Dev Behav Pediatr; 2013 Jan; 34(1):31-7. PubMed ID: 23275056
    [Abstract] [Full Text] [Related]

  • 10. Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes.
    Shah R, Diaz SD, Arria A, LaGasse LL, Derauf C, Newman E, Smith LM, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Roberts MB, Neal C, Lester BM.
    Am J Perinatol; 2012 May; 29(5):391-400. PubMed ID: 22399214
    [Abstract] [Full Text] [Related]

  • 11. Prenatal methamphetamine use and neonatal neurobehavioral outcome.
    Smith LM, Lagasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Fallone M, Liu J, Lester BM.
    Neurotoxicol Teratol; 2008 May; 30(1):20-8. PubMed ID: 18031987
    [Abstract] [Full Text] [Related]

  • 12. Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 years.
    Twomey J, LaGasse L, Derauf C, Newman E, Shah R, Smith L, Arria A, Huestis M, DellaGrotta S, Roberts M, Dansereau L, Neal C, Lester B.
    Am J Orthopsychiatry; 2013 Jan; 83(1):64-72. PubMed ID: 23330624
    [Abstract] [Full Text] [Related]

  • 13. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study.
    Nguyen D, Smith LM, Lagasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM.
    J Pediatr; 2010 Aug; 157(2):337-9. PubMed ID: 20570284
    [Abstract] [Full Text] [Related]

  • 14. School-Aged Outcomes following Prenatal Methamphetamine Exposure: 7.5-Year Follow-Up from the Infant Development, Environment, and Lifestyle Study.
    Eze N, Smith LM, LaGasse LL, Derauf C, Newman E, Arria A, Huestis MA, Della Grotta SA, Dansereau LM, Neal C, Lester BM.
    J Pediatr; 2016 Mar; 170():34-8.e1. PubMed ID: 26781836
    [Abstract] [Full Text] [Related]

  • 15. Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study.
    Smith LM, Paz MS, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Neal C, Lester BM.
    Depress Anxiety; 2012 Jun; 29(6):515-22. PubMed ID: 22555777
    [Abstract] [Full Text] [Related]

  • 16. Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study.
    Smith LM, Diaz S, LaGasse LL, Wouldes T, Derauf C, Newman E, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Neal C, Lester BM.
    Neurotoxicol Teratol; 2015 Jun; 51():35-44. PubMed ID: 26212684
    [Abstract] [Full Text] [Related]

  • 17. Effects of Prenatal Methamphetamine Exposure on Birth Outcomes, Brain Structure, and Neurodevelopmental Outcomes.
    Zhang Y, Gong F, Liu P, He Y, Wang H.
    Dev Neurosci; 2021 Jun; 43(5):271-280. PubMed ID: 34139695
    [Abstract] [Full Text] [Related]

  • 18. Do prenatally methamphetamine-exposed adult male rats display general predisposition to drug abuse in the conditioned place preference test?
    Šlamberová R, Pometlová M, Schutová B, Hrubá L, Macúchová E, Nová E, Rokyta R.
    Physiol Res; 2012 Jun; 61(Suppl 2):S129-38. PubMed ID: 23130898
    [Abstract] [Full Text] [Related]

  • 19. Postnatal development of rat pups is altered by prenatal methamphetamine exposure.
    Slamberová R, Pometlová M, Charousová P.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):82-8. PubMed ID: 16046043
    [Abstract] [Full Text] [Related]

  • 20. Prenatal Exposure to Perfluorocarboxylic Acids (PFCAs) and Fetal and Postnatal Growth in the Taiwan Maternal and Infant Cohort Study.
    Wang Y, Adgent M, Su PH, Chen HY, Chen PC, Hsiung CA, Wang SL.
    Environ Health Perspect; 2016 Nov; 124(11):1794-1800. PubMed ID: 26895313
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.